Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients.

8032Background: Older patients with classical Hodgkin lymphoma (cHL) have poor outcomes relative to younger patients, often due to comorbidities and toxicities related to standard first-line (1L) c...